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Abstract 
Background  
Disturbance of consciousness (DOC) may develop in acute pancreatitis (AP). In clinical practice, it is known that 
DOC may worsen the patient’s condition, but we have no exact data on how DOC affects the outcome of AP.  
Methods 
From the Hungarian Pancreatic Study Groups’ AP registry, 1220 prospectively collected cases were analysed, 
which contained exact data on DOC, included patients with confusion, delirium, convulsion, and alcohol 
withdrawal, answering a post hoc defined research question. Patients were separated to Non-DOC and DOC, 
whereas DOC was further divided into non-alcohol related DOC (Non-ALC DOC) and ALC DOC groups. For 
statistical analysis, independent sample t-test, Mann-Whitney, Chi-squared, or Fisher exact test were used.  
Results 
From the 1220 patients, 47 (3.9%) developed DOC, 23 (48.9%) cases were ALC DOC vs. 24 (51.1%) Non-ALC 
DOC.  
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Analysis between the DOC and Non-DOC groups showed a higher incidence of severe AP (19.2% vs. 5.3%, 
p<0.001), higher mortality (14.9% vs. 1.7%, p<0.001), and a longer length of hospitalization (LOH) (Me=11; 
IQR: 8-17 days vs. Me=9; IQR: 6-13 days, p=0.049) respectively.  
Patients with ALC DOC developed more frequently moderate AP vs. Non-ALC DOC (43.5% vs. 12.5%), while 
the incidence of severe AP was higher in Non-ALC vs. ALC DOC group (33.3% vs. 4.4%) (p<0.001). LOH 
showed a tendency to be longer in Non-ALC DOC compared to ALC DOC, respectively (Me:13; IQR:7-20 days 
vs. Me:9.5; IQR:8-15.5 days, p=0.119). 
Conclusion 
DOC during AP is associated with a higher rate of moderate and severe AP and increases the risk of mortality. 
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Introduction 
Acute pancreatitis (AP) is a sterile inflammation of the pancreas, leading to hospitalization, which is one of the 
most common among gastrointestinal diseases1. Based on the revised Atlanta classification, the severity of AP 
may be classified as mild, moderate, or severe2, the presence of local complication, and organ failure 
differentiates between the grades of severity. The prognosis of the severe form is poor; it evolves in 8.8% in AP, 
and the mortality may reach 28% in the severe cases3. In case of moderate AP, organ failure develops and 
resolves within 48 hours, while in severe forms, it persists longer2. The modified Marshall scoring system reports 
that six dysfunctional organ systems strongly correlates with mortality and intensive care unit (ICU) admission4. 
From these, renal-cardiovascular and respiratory failures are mentioned and discussed the most frequently, while 
the neurologic complications and monitoring of the Glasgow Coma Scale (GCS) are not well studied in the 
relevance of AP. 
There are several risk factors worsening severity and mortality, but there is little knowledge of the factors that 
have an effect on the outcome of the disease5-9. In clinical practice, patients with AP might present with several 
neurological symptoms, including 1) alcohol withdrawal syndrome, 2) confusion or delirium characterized by a 
disturbance of consciousness (DOC), 3) with reduced ability to focus, sustain, or shift attention with different 
etiological factors. In the pathophysiological background, during chronic alcohol exposure, N-methyl-D-
aspartate (NMDA) receptors are upregulated, and gamma-aminobutyric acid type-A (GABAA) receptors are 
downregulated, leading to tolerance. Alcohol withdrawal causes the opposite effect as enhanced NMDA receptor 
function, reduced GABAergic transmission, and dysregulation of the dopaminergic system, leading to signs of 
withdrawal syndrome like tremors, diaphoresis, tachycardia, anxiety, and seizures10. Delirium tremens is the 
most severe form of alcohol withdrawal. It is characterized by sudden and severe mental or nervous system 
changes. Leading signs are altered mental status (global confusion) and sympathetic overdrive (autonomic 
hyperactivity), which can progress to cardiovascular collapse. It is a medical emergency with a high mortality 
rate, making early recognition and treatment essential. The prevalence of delirium in the elderly population is 
between 29-64%11, and its financial burden is extreme for the health care system12 independently form the 
various etiological factors.  
The few available reports about pancreatic encephalopathy reported different hypotheses about the underlying 
mechanisms; one even concluded that it is difficult to differentiate it from Wernicke encephalopathy13. Until 
now, no study focused on the influencing role of DOC on the outcome of AP. We aimed to determine its effect 
by a cohort analysis. 
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Methods 
The Hungarian Pancreatic Study Group (HPSG) established a prospective international registry containing AP 
patients' data. All participants signed the written consent form. The study was approved by the Scientific and 
Research Ethics Committee of the Medical Research Council (22254-1/2012/EKU). For this HPSG cohort study 
data of 1220 patients were used, since they contained data about the level of consciousness during 
hospitalization. This cohort overlaps with the cohorts discussed in our previous articles3, 8, 9, but data and results 
of the analysis on DOC are only published in this report. Data were collected between January 2013 and January 
2017. Based on the presence of DOC, patients were sorted into DOC and Non-DOC groups. The DOC group 
was further divided into alcohol-related DOC (ALC DOC) and non-alcohol related DOC (Non-ALC DOC).  
 
Definition and data collection 
DOC was diagnosed if the patient had confusion, disorientation, memory deficit, hyper- or hypoactivity, or 
symptoms of alcohol withdrawal such as anxiety, shaky hands, headache, insomnia or sweating, or epileptic 
seizure; or signs of delirium. The information of DOC was collected from the prospectively collected database of 
the HPSG registry and the patients' documentation, answering a post hoc defined research question. In severe 
cases, the documentation also included psychiatric consultation. Supplementary Table 2 contains the data of 
DOC of the 47 analyzed patients: time of onset, number of episodes, duration of DOC, description of symptoms, 
and applied therapy. 
Statistical analysis 
Descriptive statistical tools were used to characterize our cohort. To examine differences between the groups, in 
case of age, we used an independent sample t-test, whereas the length of hospitalization (LOH) with the Mann-
Whitney test were analyzed. To analyze the connection between severity, mortality, and DOC, and between the 
time of onset of DOC and severity, the Chi-squared test or Fisher exact test was performed. All statistical 
analyses were done using SPSS Ver. 24 Software (IBM Corporation Armonk, New York). The significance level 
was set at 0.05. 
 
Results 
General characteristics of the entire cohort 
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A total of 1220 cases from 20 centers were analyzed. The list of centers is shown in Supplementary Table 1. 
Data were complete for age, gender, etiology of pancreatitis, LOH, the severity of acute pancreatitis, and 
mortality. Our registry included data about alcohol consumption in 99.6% (Table.1). The basic characteristics of 
the analyzed population are shown in Fig 1. More than half of our patients were male (n=683), and 46% were 
female (n=537). The most common etiological factor was biliary pancreatitis (38.4%, n=469), followed by 
idiopathic (19.2%, n=234), and alcohol-induced pancreatitis (15.2%, n=186). In the case of acute alcoholic 
pancreatitis, male dominance can be seen (male 87%, n=162; female 13%, n=24). In some cases, we found 
combined etiology (11.9%). In our study, 67.5% of the cases were mild. Moderate pancreatitis was observed in 
26.7% of cases and severe inflammation in 5.8% of the cases. The LOH was almost three times more (23.5 
days±2.5) in case of severe acute pancreatitis than in mild ones (8.6 days ± 0.17). In moderate cases, the average 
LOH was 18±0.7 days. The total mortality rate was 2.4%. In severe cases, the mortality reached 29.9%, in mild 
cases, 0.2% only, and in moderate cases, 2.2%. (Fig. 1 A-F).  
 
Demographic characteristics in DOC vs. Non-DOC groups 
From the 1220 patients of the HPSG registry, 47 patients (3.9%) developed DOC (Fig.2A). Based on the type of 
DOC, delirium (n=18), confusion (n=16), alcohol withdrawal syndrome (n=9), and convulsion (n=3) groups 
were identified. According to the etiology of DOC, in our cohort, alcohol (n=23), older age (n=9), and sepsis 
(n=6) caused the most cases of DOC. However, ischemia (n=3) hypoglycemia (n=1) and electrolyte imbalance 
(n=1) also caused DOC. In addition, 4 cases were idiopathic (Fig.2C). The male ratio was 55.4% (n=650) in the 
Non-DOC group, while 70.2% (n=33) in the DOC group. The presence of DOC showed higher incidence in men 
than in women (70.2% vs. 29.8%, n=33 vs. n=14, p=0.045) (Fig.3A). The age differed significantly between the 
groups; in the DOC group, the subjects were older (62.2 ± 18.7 vs. 56.5 ± 17 years, p=0.025) (Fig.3C). 
Supplementary Table 2. shows the data of the 47 cases with DOC. From the nine severe AP, in 3 cases were two 
episodes seen, from the 13 moderate in 1 case could be two episodes detected, while in the 25 mild cases, no one 
had two episodes. Regarding the time of onset, an analysis with the Fisher test was performed, which showed no 
significant difference (p=0.321) as to whether DOC started on the first day or other days of hospital stay. 
 
Demographic characteristics in ALC DOC vs. Non-ALC DOC groups 
From the registered 47 patients with DOC, 23 (48.9%) cases were ALC DOC, whereas 24 (51.1%) cases were 
Non-ALC DOC (Fig.2B). In the ALC DOC group, the delirium was present more often than in the Non-ALC 
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DOC group (n=12 vs. n=7), while in the Non-ALC group, the confusion with milder clinical features was more 
often present (n=15) (Fig.2C). ALC DOC showed a significant correlation with gender. It developed more 
frequently in men than women (91.3% vs. 8.7%; n=21 vs. n=2; p=0.002), while in Non-ALC DOC, no difference 
was seen between the genders (Fig.3B). Patients with Non-ALC DOC were older than patients with ALC DOC 
(70.5 ± 18.4 vs. 53.5 ± 15 years, p=0.002) (Fig.3D). 
 
Severity and mortality of AP and LOH in DOC vs. Non-DOC groups 
Analysis between the DOC and Non-DOC groups showed higher incidence of severe AP (19.2% vs. 5.3%, . 
n=9/47 vs. n=62/1173, p<0.001) (Fig.4A), 8.8 times higher mortality (14.9% vs. 1.7%, n=7/47 vs. n=20/1173, 
p<0.001) (Fig.4C), and a longer LOH in the DOC group (Me=11; IQR: 8-17 days vs. Me=9; IQR: 6-13 days, 
p=0.049) (Fig.4E) respectively.  
 
Severity and mortality of AP and LOH in ALC DOC vs. Non-ALC DOC groups 
Moderate AP developed more frequent in patients with ALC DOC vs. Non-ALC DOC group (43.5% vs. 12.5% 
n=10 vs. n=3) while the incidence of severe AP was 7 times higher in Non-ALC vs. ALC DOC group (33.3% vs. 
4.4%, n=8 vs. n=1), p<0.001 (Fig. 4B). Mortality showed no difference between the analyzed groups (n=3 vs. 
n=4) (Fig. 4D). Concerning the LOH, patients with Non-ALC DOC showed a tendency for longer hospitalization 
(Me: 13; IQR: 7-20 days vs. Me: 9.5; IQR: 8-15.5 days, p=0.119) (Fig. 4F). 
 
Discussion 
Nurses and the medical staff have an essential role in recognizing the early signs of changes in mental status and 
in preventing delirium14. However, the hospital-acquired delirium often remains unnoticed, because its 
symptoms resemble dementia and depression, further complicating the diagnosis15. Not surprising that no data is 
available concerning the relationship of DOC and the outcome of AP.   
Here we show for the first time that DOC is associated with more severe and higher mortality rates of AP. The 
question arises, which factor comes first, the severe AP, or the DOC. It is possible that due to AP released 
metabolic mediators, hypovolemia and systemic inflammatory response syndrome may lead to different organ 
failures, such as encephalopathy. On the other hand, in a patient with chronic alcohol consumption during 
hospitalization with mild AP (based on Atlanta classification), delirium tremens may occur, which is a severe 
illness in itself, which can lead to multi-organ failure, ICU admission, and mechanical ventilation. It is also 
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important to mention that the development of delirium increases the mortality risk in the intensive care unit 
(ICU), and it is also associated with longer ICU-stay16. A systematic review found that multi-component 
implementation programs with strategies, targeting ICU delirium assessment, prevention, and adequate treatment 
including pain, agitation and delirium management, and a strategy of early awakening, breathing, delirium 
screening, and early exercise have a clinical outcome improving potential17. 
 
Furthermore, we found that moderate pancreatitis is more common in the ALC DOC group, whereas in the Non-
ALC DOC group, more severe cases were detected. There was no difference in the mortality rate in the ALC 
DOC and Non-ALC DOC groups. However, there was a lower rate of severe AP in the ALC group; it had the 
same mortality rate. This difference may be explained by the fact that, in the ALC DOC group, chronic alcohol 
consumption is higher. These individuals are of lower social standing, with lower income, often malnourished, 
have vitamin deficiencies, cachexia/sarcopenia, and are at various stages of liver cirrhosis, all of which can lead 
to higher mortality in moderate AP. The other suggestion is that DOC influences mortality regardless of 
etiology. 
The findings of this study have some limitations. Based on the cohort analysis, there was a difference in the 
demographic parameters, which may influence our results. Also, between the DOC and Non-DOC and between 
the ALC and Non-ALC DOC groups’ differences in gender were seen; however, in the ALC DOC group, the 
gender distribution in alcoholic AP confirms these results. In the DOC and Non-ALC DOC groups, the average 
age is higher, which may have a causal role in the more severe course of the disease.  Besides, based on the 
analysis method, no conclusion, according to the casualty of DOC and severity could be shown, only 
associations between the parameters can be provided. 
As a clinical implication, according to our data, we can conclude that the onset of DOC is a negative prognostic 
factor in the outcome of AP. To answer this clinical question, it is necessary to organize an observational clinical 
trial to monitor all relevant parameters for DOC continuously. This observational clinical study could prove the 
real causal relationship between DOC and the outcomes of AP. Furthermore, if the observational study confirms 
our data, randomized clinical trials aiming to prevent DOC should be organized.  
Our data suggest that reducing the development of delirium should be part of the management of AP. A meta-
analysis of randomized controlled studies suggests that dexmedetomidine could be a therapeutic option 18. 
Benzodiazepines are currently in the first‐line treatment for alcohol withdrawal syndrome. They significantly 
reduce the risk of recurrent seizures related to alcohol withdrawal compared to placebo19. In the case of older 
adults and liver disease, the half‐life of diazepam increases with its accumulation and results in a higher rate of 
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side effects. In the elderly and patients with cirrhosis or severe liver dysfunction, lorazepam or oxazepam are 
preferred20. It is pivotal to recognize the symptoms of benzodiazepine toxicity because it leads to respiratory 
depression, confusion, and delirium through excessive sedation, which may be challenging to differentiate from 
delirium tremens. In older critically ill patients, polypharmacy may also play an essential role in developing 
delirium21. In the United Kingdom, the Prevention of Delirium system was implemented and delivered in several 
wards with a staff training program, and they found it feasible22. Despite the high prevalence rate of delirium and 
the marked deteriorating effects on the outcome of the different illnesses, the management of delirium lacks 
unified professional guidelines. 
 
Conclusions 
Disturbance of consciousness is associated with a more severe course of AP, longer LOH, and higher mortality 
rate of the underlying disease. Alcohol consumption in medical history elevates the rate of moderate AP in the 
DOC group.   
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Figure legends 
 
Table 1.  Quality characteristics of the Hungarian Pancreatic Study Group registry for the 1220 patients with 
acute pancreatitis. 
 
Figure 1.A. Overall gender distribution. 1.B. Distribution based on severity. 1.C. The average length of 
hospitalization in days. 1.D. Overall mortality and mortality based on severity classes. 1.E. Distribution based on 
the etiology of acute pancreatitis. 1.F. Age distribution of the population. 
 
Figure 2.A Distribution of disturbance of consciousness (DOC) of patients with acute pancreatitis (n). 2.B 
Distribution of alcohol-related DOC (ALC DOC) and non-alcohol related DOC (Non-ALC DOC) (n). 2.C 
Distribution of DOC based on type and etiology (n). 
 
Figure 3.A Sex distribution of disturbance of consciousness (DOC) and Non-DOC groups (Compared with Chi-
squared test). Figure 3.B Sex distribution of alcohol-related DOC (ALC DOC) and non-alcohol related (Non-
ALC DOC) groups (Compared with Fisher-test). 3.C Age distribution of DOC and Non-DOC groups (Compared 
with independent sample t-test). 3.D. Age distribution of ALC DOC and Non-ALC DOC groups (Compared 
with independent sample t-test). 
 
Figure. 4.A Distribution of severity of pancreatitis in disturbance of consciousness (DOC) and Non-DOC groups 
(Compared with Fisher test). 4.B Distribution of severity of acute pancreatitis of alcohol-related DOC (ALC 
DOC) and non-alcohol related (Non-ALC DOC) groups (Compared with Fisher test). 4.C Distribution of 
mortality of DOC and Non-DOC groups (Compared with Fisher test). 4.D Mortality distribution of ALC DOC 
and Non-ALC DOC groups (Compared with Fisher test). 4.E Distribution of length of hospitalization (LOH) in 
DOC and Non-DOC groups (Compared with Mann-Whitney test). 4.F Distribution of LOH in ALC DOC and 
Non-ALC DOC groups (Compared with Mann-Whitney test). 
 
Supplementary Table 1. List of centers and the distribution of the number of patients with acute pancreatitis. 
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Supplementary Table 2. Characteristics of the disturbance of consciousness (DOC) of the 47 analyzed patients: 
time of onset, number of episodes, duration of DOC, description of symptoms, applied therapy, the severity of 
acute pancreatitis (AP). N.A: not available. 
